It is estimated that alcohol contributes to around three million deaths worldwide per year. That is about five percent of all deaths each year. The major causes of alcohol-related death include alcohol poisoning, liver damage, heart failure, cancer, and car accidents.

Alcohol abuse worldwide Despite the widespread use of alcohol around the world, a global survey from 2021 of people from 30 different countries, found that around 11 percent of respondents stated alcohol abuse was the biggest health problem facing people in their country. It is currently estimated that around 1.38 percent of the global population has alcohol use disorder, however binge drinking and excessive alcohol use, both of which carry health risks, are much more common. The countries with the highest per capita consumption of alcohol include Czechia, Latvia, and the Republic of Moldova.

Alcohol consumption in the United States It is estimated that around 60 percent of adults in the United States aged 21 to 49 years currently use alcohol. Binge drinking (four or more drinks for women and five or more drinks for men on a single occasion) is most common among those aged 21 to 25 years, but still around 29 percent of those aged 40 to 44 report binge drinking. The states with the highest share of the population who binge drink are Wisconsin, North Dakota, and Montana. The death rate due to alcohol in the United States was around 13 per 100,000 population in 2020, an increase from a rate of 10.4 per 100,000 recorded in 2019.

Snapshot img

The alcoholic hepatitis treatment market share is expected to increase by USD 695.42 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 6.39%. This alcoholic hepatitis treatment market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The alcoholic hepatitis treatment market report also offers information on several market vendors, including Cadila Healthcare Ltd., Dr. Reddys Laboratories Ltd., Gilead Sciences Inc., Johnson & Johnson, Mylan NV, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. among others. Furthermore, this report extensively covers alcoholic hepatitis treatment market segmentation by type (corticosteroids, xanthine derivatives, and others) and geography (North America, Europe, Asia, and ROW).

What will the Alcoholic Hepatitis Treatment Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Alcoholic Hepatitis Treatment Market Size for the Forecast Period and Other Important Statistics

Alcoholic Hepatitis Treatment Market: Key Drivers, Trends, and Challenges

The increasing consumption of alcohol worldwide is notably driving the alcoholic hepatitis treatment market growth, although factors such as lack of therapies to treat severe alcoholic hepatitis may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the alcoholic hepatitis treatment industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Alcoholic Hepatitis Treatment Market Driver

Increasing consumption of alcohol worldwide is a major driver fueling the alcoholic hepatitis treatment market growth. Heavy consumption of alcohol leads to alcoholic hepatitis, which results in hepatic encephalopathy. There has been an increase in the consumption of alcohol globally, which resulted in increased cases of alcoholic hepatitis and mortality rates. In 2017, according to Our World in Data, worldwide alcohol disorders had the highest death toll of 184,934 due to substance use disorders. Brazil, Sub-Saharan Africa, China, India, Russia, and the US, among others, were the countries that observed a high death rate due to alcohol use disorders. Also, every year, 21,815 deaths are caused by alcohol liver diseases in the US. Furthermore, in 2016, a total of 2,744,248 resident deaths were registered in the US. Similarly, according to Eurostat, in wine-producing countries such as Spain, Italy, and Portugal, people tend to drink daily. According to Eurostat, in 2016, 18.6 liters of pure alcohol were consumed per person in Lithuania, followed by Romania (13.7 liters), Bulgaria (13.6 liters), and Belgium (13.2 liters). The COVID-19 pandemic resulted in lockdowns. With the orders of stay at home or work-from-home, the consumption of alcohol spiked in some cities of the US and India. Growing consumption of alcohol is increasing the risk of alcoholic hepatitis. This will drive the global alcoholic hepatitis treatment market during the forecast period.

Key Alcoholic Hepatitis Treatment Market Trend

The development of combination therapies to treat severe alcoholic hepatitis is a major trend influencing the alcoholic hepatitis treatment market growth. The market has witnessed the development of combination therapies to treat severe alcoholic hepatitis. Currently, there is no effective treatment for severe alcoholic hepatitis. Therefore, researchers are focusing on developing combination therapies, as they are more effective. For instance, the researchers at the University of Massachusetts Medical School are studying a combination therapy with Kineret, Trental, and zinc sulfate. During the multicenter study, the combination showed short- and long-term survival benefits in patients with severe alcoholic hepatitis with no unexpected treatment-related severe adverse events. Similarly, Gilead Sciences is conducting a Phase II clinical trial to evaluate the safety and tolerability of selonsertib (GS-4997) in combination with prednisolone in patients with severe alcoholic hepatitis. Furthermore, researchers are evaluating an antibiotic combined with a corticosteroid by targeting the group of patients at high risk of death due to alcoholic hepatitis. Also, researchers are conducting a study on N-acetylcysteine and prednisolone combination therapy for people with severe alcoholic hepatitis in order to improve short-term mortality. Such developments of combination therapies are expected to drive the growth of the market during the forecast period.

Key Alcoholic Hepatitis Treatment Market Challenge

The lack of therapies to treat severe alcoholic hepatitis is a majo

The number of alcohol-related deaths in Norway fluctuated during the period from 2008 to 2023. In 2023, there were 450 alcohol-related deaths in Norway, the highest recorded in the given interval.

Per capita alcohol consumption in the United States has increased in the past couple of decades to reach **** gallons of ethanol per capita in 2021. Beer has accounted for the largest share of the alcohol market in the United States over most of the last decade, but was overtaken by spirits for the first time in 2022. Health risks Constant and excessive alcohol use has been shown to cause many health complications and increase the risk of many diseases. For example, alcohol consumption increases the risk of various types of cancer, cardiovascular disease, and liver disease. From 2017 to 2021, the rate of new alcohol-associated cancers in the United States was around *** per 100,000 population. Liver cirrhosis A common health complication from the abuse of alcohol is liver cirrhosis. Cirrhosis is scarring of the liver from repeated injury. It can cause other health complications such as high blood pressure, bleeding, and infection, and can result in early death if left untreated. In 2019, there were over ****** alcohol-related liver cirrhosis deaths in the United States, almost double the number reported 15 years earlier.

Goal 3Ensure healthy lives and promote well-being for all at all agesTarget 3.1: By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live birthsIndicator 3.1.1: Maternal mortality ratioSH_STA_MORT: Maternal mortality ratioIndicator 3.1.2: Proportion of births attended by skilled health personnelSH_STA_BRTC: Proportion of births attended by skilled health personnel (%)Target 3.2: By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live birthsIndicator 3.2.1: Under-5 mortality rateSH_DYN_IMRTN: Infant deaths (number)SH_DYN_MORT: Under-five mortality rate, by sex (deaths per 1,000 live births)SH_DYN_IMRT: Infant mortality rate (deaths per 1,000 live births)SH_DYN_MORTN: Under-five deaths (number)Indicator 3.2.2: Neonatal mortality rateSH_DYN_NMRTN: Neonatal deaths (number)SH_DYN_NMRT: Neonatal mortality rate (deaths per 1,000 live births)Target 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseasesIndicator 3.3.1: Number of new HIV infections per 1,000 uninfected population, by sex, age and key populationsSH_HIV_INCD: Number of new HIV infections per 1,000 uninfected population, by sex and age (per 1,000 uninfected population)Indicator 3.3.2: Tuberculosis incidence per 100,000 populationSH_TBS_INCD: Tuberculosis incidence (per 100,000 population)Indicator 3.3.3: Malaria incidence per 1,000 populationSH_STA_MALR: Malaria incidence per 1,000 population at risk (per 1,000 population)Indicator 3.3.4: Hepatitis B incidence per 100,000 populationSH_HAP_HBSAG: Prevalence of hepatitis B surface antigen (HBsAg) (%)Indicator 3.3.5: Number of people requiring interventions against neglected tropical diseasesSH_TRP_INTVN: Number of people requiring interventions against neglected tropical diseases (number)Target 3.4: By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-beingIndicator 3.4.1: Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory diseaseSH_DTH_NCOM: Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease (probability)SH_DTH_NCD: Number of deaths attributed to non-communicable diseases, by type of disease and sex (number)Indicator 3.4.2: Suicide mortality rateSH_STA_SCIDE: Suicide mortality rate, by sex (deaths per 100,000 population)SH_STA_SCIDEN: Number of deaths attributed to suicide, by sex (number)Target 3.5: Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcoholIndicator 3.5.1: Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disordersSH_SUD_ALCOL: Alcohol use disorders, 12-month prevalence (%)SH_SUD_TREAT: Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders (%)Indicator 3.5.2: Alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcoholSH_ALC_CONSPT: Alcohol consumption per capita (aged 15 years and older) within a calendar year (litres of pure alcohol)Target 3.6: By 2020, halve the number of global deaths and injuries from road traffic accidentsIndicator 3.6.1: Death rate due to road traffic injuriesSH_STA_TRAF: Death rate due to road traffic injuries, by sex (per 100,000 population)Target 3.7: By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmesIndicator 3.7.1: Proportion of women of reproductive age (aged 15–49 years) who have their need for family planning satisfied with modern methodsSH_FPL_MTMM: Proportion of women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (% of women aged 15-49 years)Indicator 3.7.2: Adolescent birth rate (aged 10–14 years; aged 15–19 years) per 1,000 women in that age groupSP_DYN_ADKL: Adolescent birth rate (per 1,000 women aged 15-19 years)Target 3.8: Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for allIndicator 3.8.1: Coverage of essential health servicesSH_ACS_UNHC: Universal health coverage (UHC) service coverage indexIndicator 3.8.2: Proportion of population with large household expenditures on health as a share of total household expenditure or incomeSH_XPD_EARN25: Proportion of population with large household expenditures on health (greater than 25%) as a share of total household expenditure or income (%)SH_XPD_EARN10: Proportion of population with large household expenditures on health (greater than 10%) as a share of total household expenditure or income (%)Target 3.9: By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contaminationIndicator 3.9.1: Mortality rate attributed to household and ambient air pollutionSH_HAP_ASMORT: Age-standardized mortality rate attributed to household air pollution (deaths per 100,000 population)SH_STA_AIRP: Crude death rate attributed to household and ambient air pollution (deaths per 100,000 population)SH_STA_ASAIRP: Age-standardized mortality rate attributed to household and ambient air pollution (deaths per 100,000 population)SH_AAP_MORT: Crude death rate attributed to ambient air pollution (deaths per 100,000 population)SH_AAP_ASMORT: Age-standardized mortality rate attributed to ambient air pollution (deaths per 100,000 population)SH_HAP_MORT: Crude death rate attributed to household air pollution (deaths per 100,000 population)Indicator 3.9.2: Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services)SH_STA_WASH: Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (deaths per 100,000 population)Indicator 3.9.3: Mortality rate attributed to unintentional poisoningSH_STA_POISN: Mortality rate attributed to unintentional poisonings, by sex (deaths per 100,000 population)Target 3.a: Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriateIndicator 3.a.1: Age-standardized prevalence of current tobacco use among persons aged 15 years and olderSH_PRV_SMOK: Age-standardized prevalence of current tobacco use among persons aged 15 years and older, by sex (%)Target 3.b: Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for allIndicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programmeSH_ACS_DTP3: Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3) (%)SH_ACS_MCV2: Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2) (%)SH_ACS_PCV3: Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3) (%)SH_ACS_HPV: Proportion of the target population with access to affordable medicines and vaccines on a sustainable basis, human papillomavirus (HPV) (%)Indicator 3.b.2: Total net official development assistance to medical research and basic health sectorsDC_TOF_HLTHNT: Total official development assistance to medical research and basic heath sectors, net disbursement, by recipient countries (millions of constant 2018 United States dollars)DC_TOF_HLTHL: Total official development assistance to medical research and basic heath sectors, gross disbursement, by recipient countries (millions of constant 2018 United States dollars)Indicator 3.b.3: Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basisSH_HLF_EMED: Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis (%)Target 3.c: Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing StatesIndicator 3.c.1: Health worker density and distributionSH_MED_DEN: Health worker density, by type of occupation (per 10,000 population)SH_MED_HWRKDIS: Health worker distribution, by sex and type of occupation (%)Target 3.d: Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risksIndicator 3.d.1: International Health Regulations (IHR) capacity and health emergency preparednessSH_IHR_CAPS: International Health Regulations (IHR) capacity, by type of IHR capacity (%)Indicator 3.d.2: Percentage of bloodstream infections due to selected antimicrobial-resistant organismsiSH_BLD_MRSA: Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose

BackgroundColorectal cancer (CRC) ranks among the highest in incidence and mortality rates globally. A significant portion of Colorectal cancer cases and deaths can be attributed to modifiable risk factors, with smoking, alcohol use, and high body mass index (BMI) being the three most prominent. However, the impact of these risk factors on Colorectal cancer across regions, genders, and age groups remains insufficiently characterized.MethodsUtilizing data from the Global Burden of Disease (GBD) study 2019, restrictive cubic splines (RCS) and quantile regression analyses are applied to explore the relationship between the Socio-Demographic Index (SDI) and ASMR or ASDR. Additionally, gender differences, changes across different SDI levels, and age group trends in smoking, alcohol use, and high BMI over the 30-year period are analyzed. The Bayesian age-period-cohort (BAPC) model is employed to predict mortality trends from 2020 to 2030, aiming to explore the epidemiological and sociodemographic transitions in the Colorectal cancer disease burden attributed to smoking, alcohol use, and high BMI.ResultsIn 2019, the number of colorectal cancer deaths globally attributable to risk factors as smoking, alcohol consumption, and obesity increased to 142,931, 52,495, and 85,882 cases respectively, collectively accounting for approximately one-third of all Colorectal cancer-related deaths. Notably, there is an upward trend in early-onset Colorectal cancer mortality associated with these factors.DiscussionTo reduce the burden of Colorectal cancer, it is recommended to enhance health education, promote smoking cessation and alcohol moderation, and increase the coverage and participation in Colorectal cancer screening, which are crucial for lowering Colorectal cancer mortality rates. These findings are vital for the development of public health policies and intervention measures to reduce the global disease burden. They provide guidance for Colorectal cancer prevention across different regions, genders, and age groups worldwide.

ABSTRACT BACKGROUND: The World Health Organization (WHO) 2017 Global Conference in Montevideo, Uruguay, was dedicated to promoting successful cases and best practices in fighting and preventing noncommunicable disease (NCDs). The global effort undertaken by WHO aims to reduce road traffic deaths in order to meet goal number 3.4 of the sustainable development goals. OBJECTIVES: To describe two Brazilian road safety prevention programs, presented at the WHO 2017 Global Conference: São Paulo Traffic Safety Movement (Movimento Paulista de Segurança no Trânsito) and Safe Life Program of Brasília (Programa Brasília Vida Segura), along with their governance structures, models and results. DESIGN AND SETTING: This was a descriptive case study conducted in São Paulo and Brasilia from 2015 to 2018. These programs aimed to reduce the number of deaths caused by road accidents to 8.3 deaths per 100,000 inhabitants in São Paulo by 2020 and in Brasília by 2016; and to reduce harmful use of alcohol by 10% by 2020. METHODS: These two initiatives were designed, managed and operated to bring together government and civil society, i.e. industry, academia, non-governmental organizations (NGOs), etc., around the common goal of saving lives. They were collaborative and guided by sharing of best practices, learning and information, thereby making it possible to attain more and better results. Their format enables reproduction in cities across all Brazilian regions. RESULTS: The results attest to the efficacy of the programs implemented in these two cities. In Brasília, the initiative helped reduce the number of traffic-related deaths by 35% (2017). In the same year in the state of São Paulo, 7,600 deaths were avoided. CONCLUSION: Both programs are innovative public policies that deal with health issues caused by the external agents that ultimately account for the rapid increase in days lost to disability. Prevention of external causes of deaths and injuries, such as traffic violence, strongly correlates with changes in habits and actions, especially excessive consumption of alcohol, and with NCDs in Brazil.

BackgroundRising trends in early-onset Lip and oral cavity cancer (LOC) and Other pharyngeal cancer (OPC) burden had been observed. This study aimed to evaluate the burdens of LOC and OPC attributable to tobacco and alcohol in young adults aged 15-49 years from 1990 to 2040.MethodsTobacco- and alcohol-attributable death and disability-adjusted life years (DALYs) for LOC and OPC and the corresponding population-attributable fraction were obtained from Global Burden of Disease Study 2019 for individuals aged 15-49 years. Estimated annual percent change was calculated to quantify the temporal trend of disease burden between 1990 and 2019. The Bayesian age-period-cohort model was used to predict the age-standardized mortality rate from 2020 to 2040.ResultsIn 2019, an estimated 16,887 deaths and 799,495 DALYs for tobacco- and alcohol-attributable early-onset LOC, and 8,402 deaths and 386,418 DALYs for early-onset OPC attributable to tobacco and alcohol were reported globally. Despite the global decrease in age-standardized mortality and DALYs rates of tobacco- and alcohol-attributable LOC and OPC in young adults aged 15-49 years between 1990 and 2019, certain regions experienced increases, such as regions of Asia, Eastern Europe, and Western Sub-Saharan Africa. Moreover, a growing age-standardized mortality in individuals aged

About 228,200 Americans had a license to operate a motor vehicle in the United States in 2020. That year, an estimated 36,680 people died on U.S. roads. Traffic-related fatalities per 100,000 licensed drivers stood at 17.01 in 2020.

Road safety rankings
The United States has among the highest rates of road fatalities per population worldwide. Possible contributing factors to deaths on the road can include speeding, not wearing a seatbelt, driving while under the influence of drugs or alcohol, and driving while fatigued. Traffic fatalities caused by speeding in the United States have declined since 2008, with less than 10,000 deaths recorded annually over recent years.

Automation for the nation
94 percent of severe automobile crashes are due to human error — but driving safety is taken much more seriously today than in the past, with roughly 90 percent of U.S. drivers wearing their seatbelts while driving in 2020. Over recent years, car manufacturers and developers have striven to reduce car crashes even further with partially and fully automated safety features such as forward collision warnings, lane departure warnings, rearview video systems, and automatic emergency braking. Self-driving vehicles are also set to take to the roads in the future, with car brands such as Toyota, Ford, and GM registering over 350 autonomous driving patents respectively in the United States.

In the period of consideration, the number of road traffic fatalities in Romania peaked in 2008, totaling 3,065 deaths. Despite minor oscillations, the number of victims recorded a declining trend. Thus, by 2020 road traffic fatalities reached 1,646. This represented a decrease of roughly 40 percent compared to 2008. By contrast, the number of non-fatal road traffic injuries decreased to almost 28 thousand in 2020.

 Main causes of road traffic accidents  

In Romania, the main cause of road traffic accidents was speeding. At the same time, drinking among drivers and pedestrians who were jaywalking was still an important concern in 2019. As a consequence, there were 1,452 male car drivers under the influence of alcohol involved in car accidents in which at least one person was injured. Just as important, more than six thousand car accidents in 2019 happened because of collisions due to crossing or turning.

Crimes against road traffic safety 

Compared to the last decade, in Romania, as well as worldwide, there has been a change regarding the types of crimes committed. As a result, traditional crimes such as offenses against one’s physical and mental integrity, along with offenses against one’s property decreased. Instead, corruption offenses and crimes against road traffic safety became more common. In 2018, crimes against safety on public roads accounted for 37.6 percent of the total share of criminal law convictions.

ObjectiveThis study aims to reveal epidemiological features and trends of liver cancer (LC) in China.MethodsWe retrieved data from the Global Burden of Disease database 2019. Joinpoint regression was used to examine the temporal trend of LC. Future trends of LC were estimated using the Nordpred.ResultsThe incidence, mortality, and disability-standardized life year (DALY) rate of LC declined in China from 1990 to 2019. Among >210,000 LC cases in 2019, the LC incidences were nearly 3.15 times higher in males than in females. LC cases and LC-associated deaths were mostly found among patients aged 65 to 69 years. The proportion of LC attributable to hepatitis B decreased over time, whereas the proportions of LC attributable to hepatitis C, alcohol use, and non-alcoholic steatohepatitis increased modestly from 1990 to 2019. The majority of LC-associated deaths could be traced to four risk factors: smoking (20%), drug use (13.6%), alcohol use (11.7%), and high body mass index (10.1%). Based on the Nordpred prediction, there will be a steady decline in the incidence (39.0%) and mortality (38.3%) of liver cancer over a 25-year period from 2020 to 2044.ConclusionThe disease burden of liver cancer in China has declined over the past 30 years. However, it remains important to control liver cancer among high-risk populations, especially elderly males with obesity, alcohol use, tobacco use, and/or drug abuse.

In 2021, there were over ** million deaths from all types of cardiovascular diseases all over the world. This statistic describes the number of deaths caused by selected chronic diseases worldwide in 2021. Chronic disease has widespread consequences on both individuals, impacting both quality and length of life, as well as on societies and governments worldwide. Chronic disease The burden of chronic diseases, which is made up of the resulting disabilities and deaths, is increasing all over the globe. In 2022, lung cancer caused over *** million deaths worldwide, accounting for the highest number of cancer deaths. Furthermore, it is estimated that by 2045, there will be *** million people living with diabetes all over the globe. Although chronic diseases are not curable, their risk factors are highly preventable, usually through individual lifestyle and behavioral modifications. Public policies have been put into place in many countries worldwide to promote healthier lifestyles, for example by limiting the consumption of tobacco and alcohol. Impact on societies Chronic diseases can result in a heavy economic burden due to related health care costs and through the loss of workforce. Countries of all income statuses are affected by chronic diseases, with the leading causes of death in high-income countries from chronic disease. Moreover, the rising impact of chronic disease in low-income countries leads to a double burden, as they are forced to deal with both infectious diseases and non-communicable diseases. Weak health systems and poor economies often pose limits to these countries’ abilities to cope as well.

Deaths covering Smoking only to 2019.

The leading causes of death among the white population of the United States are cardiovascular diseases and cancer. Cardiovascular diseases and cancer accounted for a combined **** percent of all deaths among this population in 2022. In 2020 and 2021, COVID-19 was the third leading cause of death among white people. Disparities in causes of death In the United States, there exist disparities in the leading causes of death based on race and ethnicity. For example, chronic liver disease and cirrhosis is the ***** leading cause of death among the white population and the ****** among the Hispanic population, but is not among the ten leading causes for Black people. On the other hand, homicide is the ******* leading cause of death among the Black population, but is not among the 10 leading causes for whites or Hispanics. However, cardiovascular diseases and cancer by far account for the highest share of deaths for every race and ethnicity. Diseases of despair The American Indian and Alaska Native population in the United States has the highest rates of death from suicide, drug overdose, and alcohol. Together, these three behavior-related conditions are often referred to as diseases of despair. Asians have by far the lowest rates of death due to drug overdose and alcohol, as well as slightly lower rates of suicide.

Motor-vehicle deaths in the United States have decreased greatly since the 1970s and 1980s. In 2023, there were around **** deaths from motor vehicles per 100,000 population, compared to a rate of **** deaths per 100,000 in 1970. Laws requiring drivers and passengers to wear safety belts and advancements in safety technology in vehicles are major drivers for these reductions. Motor-vehicle accidents in the U.S. Americans spend a significant amount of time behind the wheel. Many cities lack convenient and reliable public transportation and, especially in rural areas, cars are a necessary means of transportation. In 2020, August was the month with the highest number of fatal crashes, followed by September and June. The deadliest time of day for fatal vehicle crashes is between * and * p.m., most likely due to the after-work rush hour and more people who are under the influence of alcohol. Drinking and driving among youth Drinking and driving remains a relevant problem across the United States and can be especially problematic among younger people. In 2023, around *** percent of those aged 21 to 25 years in the United States reported driving under the influence of alcohol in the preceding year. Furthermore, around ***** percent of those aged 16 to 20 drove after drinking within the past year.

In the past few years the number of deaths from cocaine overdose has risen in the United States, with almost ****** such deaths in 2022. Deaths involving cocaine are more common among males than females, with deaths among males more than double that of females in 2022. It is important to note that many overdose deaths involving cocaine also involve the use of other drugs, in particular opioids, which may contribute to death. Cocaine use Cocaine is one of the most commonly used illicit drugs in the United States. As of 2022, over ** million people had used cocaine in their lifetime, an increase from **** million in 2009. Furthermore, almost *** million people in the U.S. used cocaine in the past year as of 2022. Cocaine use among teens The lifetime prevalence of cocaine use among high school students in the U.S. has decreased in recent years. As of 2022, around *** percent of high school students stated they had used cocaine in their lifetime. Nevertheless, around **** percent of high school students state that cocaine is “fairly easy” or “very easy” to obtain.

The leading causes of death in the United States have changed significantly from the year 1900 to the present. Leading causes of death in 1900, such as tuberculosis, gastrointestinal infections, and diphtheria have seen huge decreases in death rates and are no longer among the leading causes of death in the United States. However, other diseases such as heart disease and cancer have seen increased death rates. Vaccinations One major factor contributing to the decrease in death rates for many diseases since the year 1900 is the introduction of vaccinations. The decrease seen in the rates of death due to pneumonia and influenza is a prime example of this. In 1900, pneumonia and influenza were the leading causes of death, with around *** deaths per 100,000 population. However, in 2023 pneumonia and influenza were not even among the ten leading causes of death. Cancer One disease that has seen a large increase in death rates since 1900 is cancer. Cancer currently accounts for almost ** percent of all deaths in the United States, with death rates among men higher than those for women. The deadliest form of cancer for both men and women is cancer of the lung and bronchus. Some of the most common avoidable risk factors for cancer include smoking, drinking alcohol, sun exposure, and obesity.

Cancer was responsible for around *** deaths per 100,000 population in the United States in 2023. The death rate for cancer has steadily decreased since the 1990’s, but cancer still remains the second leading cause of death in the United States. The deadliest type of cancer for both men and women is cancer of the lung and bronchus which will account for an estimated ****** deaths among men alone in 2025. Probability of surviving Survival rates for cancer vary significantly depending on the type of cancer. The cancers with the highest rates of survival include cancers of the thyroid, prostate, and testis, with five-year survival rates as high as ** percent for thyroid cancer. The cancers with the lowest five-year survival rates include cancers of the pancreas, liver, and esophagus. Risk factors It is difficult to determine why one person develops cancer while another does not, but certain risk factors have been shown to increase a person’s chance of developing cancer. For example, cigarette smoking has been proven to increase the risk of developing various cancers. In fact, around ** percent of cancers of the lung, bronchus and trachea among adults aged 30 years and older can be attributed to cigarette smoking. Other modifiable risk factors for cancer include being obese, drinking alcohol, and sun exposure.

In 2022, there were an estimated 2.48 million new cases of trachea, bronchus, and lung cancer worldwide. Breast cancer was the second most common cancer type at that time with around 2.3 million new cases worldwide.

Number of new cancer cases

Cancer can be caused by internal factors like genetics and mutations, as well as external factors such as smoking and radiation. It occurs in the presence of uncontrolled growth and spread of abnormal cells. However, many cancer cases could be prevented, for example, by omitting cigarette usage and heavy alcohol consumption. Risk of developing cancer tends to increase with age and is most common in older adults. Nevertheless, cancer can develop in individuals of any age. Cancer can be treated through surgery, radiation, and chemotherapy, among other methods.

In the United States, there will be an estimated two million new cancer cases and 611,720 deaths in 2024. Among U.S. men, prostate cancer and lung and bronchus cancers are the most common cancer types as of 2024, totaling an estimated 299,010 and 116,310 cases, respectively. In women, breast cancer and lung and bronchus cancer are the most common newly diagnosed types, totaling 310,720 and 118,270 cases, respectively.

In 2021, South Korea had the lowest rate of death from ischemic heart disease among OECD countries, with around ** deaths per 100,000 inhabitants. In comparison, there were around *** deaths due to ischemic heart disease per 100,000 population in Lithuania. Cardiovascular disease worldwide Fatty deposits accumulating in the inner wall of the coronary artery which restrict blood flow to the heart cause ischemic heart disease (IHD) and can also precipitate heart attacks and strokes. Cardiovascular risk factors such as smoking, heavy alcohol use, and unhealthy diet are more prevalent in Eastern European countries, contributing to a much higher burden of cardiovascular diseases and deaths. In Russia, the general public greatly underestimates the burden of cardiovascular diseases with the actual number of deaths over ** percent higher than what people estimate. Prevention and intervention Invasive interventions for heart disease can include surgical procedures such as heart bypass surgery- where blood is diverted around clogged parts of major arteries- which ranges in cost around the world. Other medical interventions include the use of prescribed or over-the-counter drugs, such as prescription nitrates or beta blockers, or OTC medications like aspirin. Lifestyle factors to lower blood pressure and cholesterol levels can help decrease risk of heart attacks and other cardiovascular diseases, including maintaining a healthy diet, regular physical activity, and smoking and alcohol cessation.